Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
P. Levy (Grenoble, France). Should obstructive sleep apnoea be treated regarding the related cardiovascular risk in non sleepy patients?. Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases

Member's Comments

No comment yet.

Related content which might interest you: Treatment with CPAP reduces mortality in patients with obstructive sleep apnoea syndrome within less than 3 years Source: Annual Congress 2006 - Therapeutic effects in obstructive sleep apnoea Year: 2006 Obstructive sleep apnea Source: Respipedia Article Year: 2017 Effect of continuous positive airway pressure treatment on hypoadiponectinemia in male patients with obstructive sleep apnea syndrome Source: Annual Congress 2005 - Metabolic control in OSA Year: 2005 Wrist-actigraphic estimation of sleep time under nCPAP treatment in sleep apnoea patients Source: Eur Respir J 2004; 23: 891-895 Year: 2004 Are symptoms of obstructive sleep apnoea related to good continuous positive airway pressure compliance? Source: ERJ Open Res, 6 (3) 00169-2019; 10.1183/23120541.00169-2019 Year: 2020 Cardiac sympathovagal balance during sleep in obstructive sleep apnea patients is different under auto-adjusting CPAP than fixed-CPAP treatment Source: Annual Congress 2006 - Therapeutic effects in obstructive sleep apnoea Year: 2006 Treatment of obstructive sleep apnoea with nasal continuous positive airway pressure in stroke Source: Eur Respir J 2001; 18: 623-629 Year: 2001 Sympathetic activity is reduced by nCPAP in hypertensive obstructive sleep apnoea patients Source: Eur Respir J 2004; 23: 255-262 Year: 2004 Efficacy of continuous positive airway pressure treatment to resistant hypertension in patients with obstructive sleep apnea syndrome Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy Year: 2008 Does positional apnea influence optimum continuous positive airway pressure (CPAP) in obstructive sleep apnea (OSA)? Source: Eur Respir J 2005; 26: Suppl. 49, 111s Year: 2005 Compliance in sleep apnoea therapy: influence of home care support and pressure mode Source: Eur Respir J 2009; 33: 804-811 Year: 2009 Twenty years compliance with continuous positive air pressure treatment in patients with severe obstructive sleep apnea Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects Year: 2019 Compliance with continuous positive airway pressure in patients with sleep apnea/hypopnea syndrome Source: Annual Congress 2007 - Sleep apnoea Year: 2007 Is the daily duration of nasal CPAP ventilation the main determinant of improvement of blood gases in OSAS (obstructive sleep apnoea syndrome) patients? Source: Eur Respir J 2001; 18: Suppl. 33, 390s Year: 2001 Does personality change in obstructive sleep apnea (OSA) patients using CPAP? Source: Eur Respir J 2006; 28: Suppl. 50, 409s Year: 2006 Prediction of effective continuous positive airway pressure (CPAP) in obstructive sleep apnea syndrome (OSA) Source: Eur Respir J 2005; 26: Suppl. 49, 111s Year: 2005 Auto-titrating CPAP for treating obstructive sleep apnoea, a bimodal response in males? Source: Eur Respir J 2006; 28: Suppl. 50, 409s Year: 2006 Effects of continuous positive airway pressure (CPAP) on quality of life in patients with obstructive sleep apnea syndromes (OSAS) Source: Annual Congress 2010 - Clinical aspects of sleep apnoea Year: 2010 Recommendations for the management of patients with obstructive sleep apnoea and hypertension Source: Eur Respir J 2013; 41: 523-538 Year: 2013 Cardiovascular regulation effects of CPAP therapy in obstructive sleep apnea patients with and without hypertension during daytime Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II Year: 2012